In addition to liver cirrhosis and HCC as endpoints, two indicators of ongoing viral replication (serum HBV DNA level, presence or persistence of viral replication (HBeAg)) and two of hepatic damage (elevated serum alanine transaminase (ALT) and degree of hepatic fibrosis) were included. The gene discussed is GPT; the disease is Hepatic fibrosis.